Following amofor’s exceptional debut at AAPS in Boston last year, resulting in the creation of valuable new partnerships and client relationships, we look forward to returning to PharmSci 360 this month in Orlando, Florida. The event brings together in one spot key industry researchers and decision-makers, offering an unparalleled opportunity for networking, sharing advancements, and connecting with both customers and partners. It’s a dynamic environment where diverse facets of the pharmaceutical world converge, making it very easy to engage and collaborate.
amofor’s Pioneering Path in Revolutionizing Formulations
Amidst the busy setting of AAPS, amofor stands out with its commitment to get drug molecules faster formulated using unique in-silico techniques. Formulation development is a complex challenge and carries numerous obstacles that must be overcome to achieve success. In this respect, our pioneering approach to amorphous solid dispersions, a very unique and recently emerging formulation technique, has given us an edge in the industry. We are the first ones that have developed a completely in silico approach to forecast the behavior of such formulations and guide their design. This contrasts with the status quo, which heavily relies on experimental screenings that require a lot of experimental work and material.
Tailored Solutions through Systematic Methodology
Our experience is replete with challenges brought to us by clients. Often, our customers present us with limited data sets coupled with issues they can’t decipher. They voice concerns like: “We are struggling with issues in our formulation project that we did not have last time.” or “Why are we suddenly seeing crystallization?”. Many formulators fear unexpected results from stability tests, uncertain if their formulation will change over time. This uncertainty is still major reason for choosing conventional formulation pathways, regardless of the huge advantages an amorphous solid dispersion has. Leveraging our systematic modeling approach, we provide clarity, deeper insights, and ultimately de-risk the formulation development process.
An Invitation to Collaborate
As AAPS in Orlando approaches, amofor extends a warm invitation to partners and attendees. If you are a formulation developer and grappling with solubility issues or hesitant about formulating your products as an amorphous or dispersion, let’s address it together.
Bring us the problems you’ve experienced lately and discuss at booth #2846 with amofor’s CEO, Dr. Christian Lübbert, what amofor can offer!
Contact us to schedule an appointment during AAPS. We are looking forward to talking with you there!